References
- Altman BJ, Hsieh AL, Sengupta A, Krishnanaiah SY, Stine ZE, Walton ZE, Gouw AM, Venkataraman A, Li B, Goraksha-Hicks P, et al. 2015. MYC disrupts the circadian clock and metabolism in cancer cells. Cell Metab. 22(6):1009–1019. doi:https://doi.org/10.1016/j.cmet.2015.09.003.
- Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2017. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 66(4):683–691. doi:https://doi.org/10.1136/gutjnl-2015-310912.
- Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. 2000. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 25(1):25–29. doi:https://doi.org/10.1038/75556.
- Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML. 2013. bHLH-PAS proteins in cancer. Nat Rev Cancer. 13(12):827–841. doi:https://doi.org/10.1038/nrc3621.
- Bläker H, Helmchen B, Bönisch A, Aulmann S, Penzel R, Otto HF, Rieker RJ. 2004. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Scand J Gastroenterol. 39(8):748–753. doi:https://doi.org/10.1080/00365520410005847.
- Blank A, Roberts DE 2nd, Dawson H, Zlobec I, Lugli A. 2018. Tumor heterogeneity in primary colorectal cancer and corresponding metastases. Does the apple fall far from the tree? Front Med (Lausanne). 5:234. doi:https://doi.org/10.3389/fmed.2018.00234
- Carmon KS, Gong X, Lin Q, Thomas A, Liu Q. 2011. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A. 108(28):11452–11457. doi:https://doi.org/10.1073/pnas.1106083108.
- Dinu D, Dobre M, Panaitescu E, Bîrlă R, Iosif C, Hoara P, Caragui A, Boeriu M, Constantinoiu S, Ardeleanu C. 2014. Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study. J Med Life. 7(4):581–587. PMID: 25713627; PMCID: PMC4316144.
- Doi M, Hirayama J, Sassone-Corsi P. 2006. Circadian regulator CLOCK is a histone acetyltransferase. Cell. 125(3):497–508. doi:https://doi.org/10.1016/j.cell.2006.03.033.
- Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. 2007. A systems biology approach for pathway level analysis. Genome Res. 17(10):1537–1545. doi:https://doi.org/10.1101/gr.6202607.
- Emmert-Streib F, Dehmer M, Haibe-Kains B. 2014. Gene regulatory networks and their applications: understanding biological and medical problems in terms of networks. Front Cell Dev Biol. 2:38. doi:https://doi.org/10.3389/fcell.2014.00038
- Farshadi E, Yan J, Leclere P, Goldbeter A, Chaves I, Van Der Horst GTJ. 2019. The positive circadian regulators CLOCK and BMAL1 control G2/M cell cycle transition through Cyclin B1. Cell Cycle. 18(1):16–33. doi:https://doi.org/10.1080/15384101.2018.1558638.
- Gu D, Li S, Ben S, Du M, Chu H, Zhang Z, Wang M, Zhang ZF, Chen J. 2018. Circadian clock pathway genes associated with colorectal cancer risk and prognosis. Arch Toxicol. 92(8):2681–2689. doi:https://doi.org/10.1007/s00204-018-2251-7.
- Huang Da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4(1):44–57. doi:https://doi.org/10.1038/nprot.2008.211.
- Itatani Y, Kawada K, Sakai Y. 2019. Transforming growth factor-β signaling pathway in colorectal cancer and its tumor microenvironment. Int J Mol Sci. 20(23):5822. doi:https://doi.org/10.3390/ijms20235822.
- Jung YS, Jun S, Lee SH, Sharma A, Park JI. 2015. Wnt2 complements Wnt/β-catenin signaling in colorectal cancer. Oncotarget. 6(35):37257–37268. doi:https://doi.org/10.18632/oncotarget.6133.
- Karantanos T, Theodoropoulos G, Pektasides D, Gazouli M. 2014. Clock genes: their role in colorectal cancer. World J Gastroenterol. 20(8):1986–1992. doi:https://doi.org/10.3748/wjg.v20.i8.1986.
- Kim P, Oster H, Lehnert H, Schmid SM, Salamat N, Barclay JL, Maronde E, Inder W, Rawashdeh O. 2019. Coupling the circadian clock to homeostasis: the role of period in timing physiology. Endocr Rev. 40(1):66–95. doi:https://doi.org/10.1210/er.2018-00049.
- Li HX. 2019. The role of circadian clock genes in tumors. Onco Targets Ther. 12:3645–3660. doi:https://doi.org/10.2147/OTT.S203144
- Marisa L, De Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D, Ayadi M, et al. 2013. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 10(5):e1001453. doi:https://doi.org/10.1371/journal.pmed.1001453.
- Momma T, Okayama H, Saitou M, Sugeno H, Yoshimoto N, Takebayashi Y, Ohki S, Takenoshita S. 2017. Expression of circadian clock genes in human colorectal adenoma and carcinoma. Oncol Lett. 14(5):5319–5325. doi:https://doi.org/10.3892/ol.2017.6876.
- Nader N, Chrousos GP, Kino T. 2009. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J. 23(5):1572–1583. doi:https://doi.org/10.1096/fj.08-117697.
- Ogino S, Shima K, Meyerhardt JA, McCleary NJ, Ng K, Hollis D, Saltz LB, Mayer RJ, Schaefer P, Whittom R, et al. 2012. Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clin Cancer Res. 18(3):890–900. doi:https://doi.org/10.1158/1078-0432.CCR-11-2246.
- Panigrahy D, Kaipainen A, Kieran MW, Huang S. 2008. PPARs: a double-edged sword in cancer therapy? PPAR Res. 2008:350351. doi:https://doi.org/10.1155/2008/350351
- Pezzuto A, Carico E. 2018. Role of HIF-1 in cancer progression: novel insights. A review. Curr Mol Med. 18(6):343–351. doi:https://doi.org/10.2174/1566524018666181109121849.
- Porru M, Pompili L, Caruso C, Biroccio A, Leonetti C. 2018. Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities. J Exp Clin Cancer Res. 37(1):57. doi:https://doi.org/10.1186/s13046-018-0719-1.
- Pritchard CC, Grady WM. 2011. Colorectal cancer molecular biology moves into clinical practice. Gut. 60(1):116–129. doi:https://doi.org/10.1136/gut.2009.206250.
- Santarpia L, Lippman SM, El-Naggar AK. 2012. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 16(1):103–119. doi:https://doi.org/10.1517/14728222.2011.645805.
- Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11):2498–2504. doi:https://doi.org/10.1101/gr.1239303.
- Sun S, Klebaner F, Tian T. 2014. A new model of time scheme for progression of colorectal cancer. BMC Syst Biol. 8(Suppl3):S2. doi:https://doi.org/10.1186/1752-0509-8-S3-S2.
- Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. 2017. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1):W98–W102. doi:https://doi.org/10.1093/nar/gkx247.
- Tsukamoto S, Ishikawa T, Iida S, Ishiguro M, Mogushi K, Mizushima H, Uetake H, Tanaka H, Sugihara K. 2011. Clinical significance of osteoprotegerin expression in human colorectal cancer. Clin Cancer Res. 17(8):2444–2450. Epub 2011 Jan 26. PMID: 21270110. doi:https://doi.org/10.1158/1078-0432.CCR-10-2884.
- von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. 2003. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 31(1):258–261. doi:https://doi.org/10.1093/nar/gkg034.
- Yang L, Liu Z, Tan J, Dong H, Zhang X. 2018. Multispectral imaging reveals hyper active TGF-β signaling in colorectal cancer. Cancer Biol Ther. 19(2):105–112. Epub 2017 Dec 8. PMID: 29219668; PMCID: PMC5790339. doi:https://doi.org/10.1080/15384047.2017.1395116.
- Ye Y, Xiang Y, Ozguc FM, Kim Y, Liu CJ, Park PK, Hu Q, Diao L, Lou Y, Lin C, et al. 2018. The genomic landscape and pharmacogenomic interactions of clock genes in cancer chronotherapy. Cell Syst. 6(3):314–328.e2. Epub 2018 Mar 7. PMID: 29525205; PMCID: PMC6056007. doi:https://doi.org/10.1016/j.cels.2018.01.013.
- Zhan T, Rindtorff N, Boutros M. 2017. Wnt signaling in cancer. Oncogene. 36(11):1461–1473. Epub 2016 Sep 12. PMID: 27617575; PMCID: PMC5357762. doi:https://doi.org/10.1038/onc.2016.304.
- Zhang J, Roberts TM, Shivdasani RA. 2011. Targeting PI3K signaling as a therapeutic approach for colorectal cancer. Gastroenterology. 141(1):50–61. PMID: 21723986. doi:https://doi.org/10.1053/j.gastro.2011.05.010.
- Zhao WX, Tian M, Zhao BX, Li GD, Liu B, Zhan YY, Chen HZ, Wu Q. 2007. Orphan receptor TR3 attenuates the p300-induced acetylation of retinoid X receptor-alpha. Mol Endocrinol. 21(12):2877–2889. Epub 2007 Aug 30. PMID: 17761950. doi:https://doi.org/10.1210/me.2007-0107.